Akari Therapeutics (AKTX) Cash from Operations (2014 - 2026)
Akari Therapeutics recorded quarterly Cash from Operations of 2488000.0 in Q1 2026, up 18.18% quarter-over-quarter from 3041000.0 in Q4 2025, and down 15.72% year-over-year from 2952097.13 in Q1 2025.
Akari Therapeutics' Cash from Operations history runs 13 years deep, the most recent figure standing at 2488000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 15.72% year-over-year to 2488000.0; the TTM figure through Mar 2026 stood at 10906000.0 (down 2.33% YoY), while the FY2025 annual figure was 10568000.0, up 15.81% from the prior year.
- Cash from Operations came in at 2488000.0 for Q1 2026 at Akari Therapeutics, up from 3041000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1490000.0 in Q3 2024 to a low of 8573730.0 in Q2 2022.
- A 5-year average of 3710889.4 and a median of 3256000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 76.21% in 2022 and surged 51.83% in 2024, its largest moves.
- Akari Therapeutics' Cash from Operations stood at 8573730.0 in 2022, then soared by 48.58% to 4409000.0 in 2023, then soared by 51.83% to 2124000.0 in 2024, then tumbled by 43.17% to 3041000.0 in 2025, then increased by 18.18% to 2488000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 2488000.0, 3041000.0, and 2121000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.49 Mn |
| Mar 31, 2026 | -2.49 Mn |
| Dec 31, 2025 | -3.04 Mn |
| Dec 31, 2025 | -3.04 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -3.26 Mn |
| Jun 30, 2025 | -3.26 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -4.89 Mn |
| Jun 30, 2024 | -4.89 Mn |
| Mar 31, 2024 | -4.04 Mn |
| Mar 31, 2024 | -4.04 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -4.69 Mn |
| Jun 30, 2023 | -4.69 Mn |
| Mar 31, 2023 | -4.88 Mn |
| Mar 31, 2023 | -4.88 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | -5.05 Mn |
| Mar 31, 2022 | -5.05 Mn |
| Dec 31, 2021 | 13,842.66 Bn |
| Dec 31, 2021 | 13,842.66 Bn |
| Sep 30, 2021 | -13,842.64 Bn |
| Sep 30, 2021 | -13,842.64 Bn |
| Jun 30, 2021 | -4.87 Mn |
| Jun 30, 2021 | -4.87 Mn |
| Mar 31, 2021 | -7.42 Mn |
| Mar 31, 2021 | -7.42 Mn |
| Dec 31, 2020 | 12,717.27 Bn |
| Dec 31, 2020 | 12,717.27 Bn |
| Sep 30, 2020 | -12,717.27 Bn |
| Sep 30, 2020 | -12,717.27 Bn |
| Jun 30, 2020 | 7,739.64 Bn |
| Jun 30, 2020 | 7,739.64 Bn |
| Mar 31, 2020 | -7,739.66 Bn |
| Mar 31, 2020 | -7,739.66 Bn |
| Dec 31, 2019 | -3.46 Mn |
| Dec 31, 2019 | -3.46 Mn |
| Sep 30, 2019 | -4.91 Mn |
| Sep 30, 2019 | -4.91 Mn |
| Jun 30, 2019 | -4.77 Mn |
| Jun 30, 2019 | -4.77 Mn |
| Mar 31, 2019 | 228,944.00 |
| Mar 31, 2019 | 228,944.00 |
| Dec 31, 2018 | -4.76 Mn |
| Dec 31, 2018 | -4.76 Mn |
| Sep 30, 2018 | -5.33 Mn |
| Sep 30, 2018 | -5.33 Mn |
| Jun 30, 2018 | -8.28 Mn |
| Jun 30, 2018 | -8.28 Mn |
| Mar 31, 2018 | -4.40 Mn |
| Mar 31, 2018 | -4.40 Mn |
| Dec 31, 2017 | -8.52 Mn |
| Dec 31, 2017 | -8.52 Mn |
| Sep 30, 2017 | -9.21 Mn |
| Sep 30, 2017 | -9.21 Mn |
| Jun 30, 2017 | -4.70 Mn |
| Jun 30, 2017 | -4.70 Mn |
| Mar 31, 2017 | -9.17 Mn |
| Mar 31, 2017 | -9.17 Mn |
| Dec 31, 2016 | -6.49 Mn |
| Dec 31, 2016 | -6.49 Mn |
| Sep 30, 2016 | -5.00 Mn |
| Sep 30, 2016 | -5.00 Mn |
| Jun 30, 2016 | -5.69 Mn |
| Jun 30, 2016 | -5.69 Mn |
| Mar 31, 2016 | -7.44 Mn |
| Mar 31, 2016 | -7.44 Mn |
| Dec 31, 2015 | -6.77 Mn |
| Dec 31, 2015 | -6.77 Mn |
| Sep 30, 2015 | 4.49 Mn |
| Sep 30, 2015 | 4.49 Mn |
| Jun 30, 2015 | -697,543.00 |
| Jun 30, 2015 | -697,543.00 |
| Mar 31, 2015 | -1.99 Mn |
| Mar 31, 2015 | -1.99 Mn |
| Dec 31, 2014 | -667,978.00 |
| Dec 31, 2014 | -667,978.00 |
| Sep 30, 2014 | 3.57 Mn |
| Sep 30, 2014 | 3.57 Mn |
| Jun 30, 2014 | -2.33 Mn |
| Jun 30, 2014 | -2.33 Mn |
| Mar 31, 2014 | -2.05 Mn |
| Mar 31, 2014 | -2.05 Mn |